Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.110
-0.140 (-11.20%)
At close: Dec 20, 2024, 4:00 PM
1.100
-0.010 (-0.90%)
After-hours: Dec 20, 2024, 6:49 PM EST
Alzamend Neuro Employees
As of April 30, 2024, Alzamend Neuro had 7 total employees, including 4 full-time and 3 part-time employees. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$843,367
Market Cap
6.03M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cutera | 430 |
T2 Biosystems | 113 |
PAVmed | 107 |
Kindly MD | 65 |
Vincerx Pharma | 42 |
Addex Therapeutics | 23 |
Quantum BioPharma | 17 |
Adial Pharmaceuticals | 7 |
ALZN News
- 4 months ago - Alzamend Neuro Stock Jumps After Post Traumatic Stress Disorder Study Pact: Details - Benzinga
- 4 months ago - Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder - Business Wire
- 8 months ago - Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program - Business Wire
- 1 year ago - Altasciences Completes Clinical Portion of Alzamend Neuro's Phase IIa Multiple Ascending Dose Clinical Trial for Treatment of Dementia Related to Alzheimer's - Business Wire
- 1 year ago - Ault Alliance Announces Alzamend Neuro Has Initiated Its Phase I/IIA Trial for Its Immunotherapy Vaccine (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimer's Type - Business Wire
- 2 years ago - BitNile Holdings Contemplates Exchange Offer to Acquire Shares of Its Common Stock - Business Wire
- 2 years ago - In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Stephan Jackman, CEO Alzamend Neuro, Inc. - Accesswire
- 2 years ago - BitNile Holdings Reports Third Quarter 2022 Financial Results, Including Revenue of $100 Million for the Nine Months Ended September 30, 2022, up 124% from the Prior Year's Nine-Month Period - Business Wire